datafinder.stats.govt.nz cigarette smoking behaviour regional council Frontiers 2023_Census_totals_by_topic_for_individuals_by_SA2_part_1_lookup_table | Stats NZ Geographic

427.304 Adjustments for changes to billing and payment codes

(3) To determine whether a drug or biological product is a Part B rebatable drug under this section, CMS will use the most recent available data submitted to CMS by manufacturers pursuant to section 1927(b)(3)(A)(iii) of the Act or section 1847A(f)(2), as applicable, and other available data, including but not limited to information available at FDA.gov and information in drug pricing compendia, as applicable

doi: 10.1371/journal.pone.0267003 71

Boysen, G

We note that understanding the barriers to utilizing these codes is important, as these codes will serve as the base codes for HCPCS code GIDXX, and will need to be billed by the infectious disease physician prior to billing HCPCS code GIDXX